Company intelligence / Profile preview
Shenzhen Kangtai Biological Products
Shenzhen, Guangdong, Chinaen.biokangtai.com ↗
- Ownership
- Private
- Employees
- ~2000
- Development stage
- Commercial
01
Overview
Shenzhen Kangtai Biological Products has over a dozen approved or emergency-use human vaccine products. These include the world’s first approved high-dose hepatitis B vaccine and several COVID‑19 vaccines. The company’s COVID‑19 inactivated vaccine was approved for emergency use in China in May 2021. Its adenovirus-vectored COVID‑19 vaccine received approval as a booster dose in Indonesia. The company also holds exclusive rights to manufacture the Oxford–AstraZeneca COVID‑19 vaccine for mainland China
- Therapeutic areas
- Infectious Diseases
- Modalities
- Live attenuated viral vaccinesinactivated viral vaccinesrecombinant protein vaccinesbacterial polysaccharide vaccinesbacterial polysaccharide conjugate vaccinescombination vaccinesviral vector vaccinesmRNA vaccines
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
Request access →03
Partnerships
AstraZeneca – exclusive manufacturing of Oxford–AstraZeneca COVID–19 vaccine for mainland ChinaImmorna Hangzhou Biotechnology – collaboration on mRNA platform development via subsidiary Minhai BiotechnologyPhil. Pharmawealth Inc. – licensing agreement via Beijing Minhai
Beyond the preview
Go deeper on Shenzhen Kangtai Biological Products.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Kangtai Biological Products.